The Cutoff Values of Visceral Fat in Metabolic Syndrome: Evidence fromStudies

Abstract

Metabolic syndrome (MetS) is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance, diabetes, and increased risk of developing cardiovascular disease and death. Visceral fat (VF) is a risk factor for multiple CVD risk factors, including endothelial dysfunction, hypertension, dyslipidemia, diabetes, impaired glucose metabolism, insulin resistance), liver insulin resistance, non-alcoholic fatty liver disease, sleep apnea. Visceral obesity is associated with higher occurrence of cardiovascular events [1-6].